PATCH - Prostate adenocarcinoma: transcutaneous hormones. A randomised comparison evaluating cardiovascular morbidity and mortality of transdermal oestradiol versus luteinising hormone-releasing hormone agonists in advanced prostate cancer
- Publication date
- 1 June 2018
- Publisher
- The British Associations of Urological Surgeons (BAUS) Annual Scientific Meeting
